X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Abbott India with Torrent Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs TORRENT PHARMA - Comparison Results

ABBOTT INDIA    Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

TORRENT PHARMA 
   Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA TORRENT PHARMA ABBOTT INDIA/
TORRENT PHARMA
 
P/E (TTM) x 41.7 29.1 143.1% View Chart
P/BV x 10.4 5.5 188.1% View Chart
Dividend Yield % 0.6 1.0 65.5%  

Financials

 ABBOTT INDIA   TORRENT PHARMA
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-16
TORRENT PHARMA
Mar-17
ABBOTT INDIA/
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs6,0151,768 340.3%   
Low Rs3,7071,186 312.7%   
Sales per share (Unadj.) Rs1,236.9346.1 357.4%  
Earnings per share (Unadj.) Rs122.255.2 221.5%  
Cash flow per share (Unadj.) Rs129.073.3 175.9%  
Dividends per share (Unadj.) Rs35.0014.00 250.0%  
Dividend yield (eoy) %0.70.9 75.9%  
Book value per share (Unadj.) Rs521.2257.1 202.8%  
Shares outstanding (eoy) m21.25169.22 12.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.94.3 92.1%   
Avg P/E ratio x39.826.8 148.6%  
P/CF ratio (eoy) x37.720.1 187.1%  
Price / Book Value ratio x9.35.7 162.3%  
Dividend payout %28.625.4 112.9%   
Avg Mkt Cap Rs m103,296249,887 41.3%   
No. of employees `0003.011.8 25.1%   
Total wages/salary Rs m3,3709,934 33.9%   
Avg. sales/employee Rs Th8,891.84,971.5 178.9%   
Avg. wages/employee Rs Th1,140.0843.2 135.2%   
Avg. net profit/employee Rs Th878.3792.4 110.8%   
INCOME DATA
Net Sales Rs m26,28458,569 44.9%  
Other income Rs m5042,233 22.6%   
Total revenues Rs m26,78960,802 44.1%   
Gross profit Rs m3,66513,773 26.6%  
Depreciation Rs m1443,069 4.7%   
Interest Rs m82,056 0.4%   
Profit before tax Rs m4,01710,881 36.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,4211,545 92.0%   
Profit after tax Rs m2,5969,336 27.8%  
Gross profit margin %13.923.5 59.3%  
Effective tax rate %35.414.2 249.1%   
Net profit margin %9.915.9 62.0%  
BALANCE SHEET DATA
Current assets Rs m14,44653,841 26.8%   
Current liabilities Rs m4,72531,612 14.9%   
Net working cap to sales %37.038.0 97.4%  
Current ratio x3.11.7 179.5%  
Inventory Days Days5197 52.9%  
Debtors Days Days2084 23.3%  
Net fixed assets Rs m1,11342,079 2.6%   
Share capital Rs m213846 25.1%   
"Free" reserves Rs m10,80842,655 25.3%   
Net worth Rs m11,07643,501 25.5%   
Long term debt Rs m022,408 0.0%   
Total assets Rs m16,241101,250 16.0%  
Interest coverage x497.06.3 7,896.7%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x1.60.6 279.8%   
Return on assets %16.011.3 142.5%  
Return on equity %23.421.5 109.2%  
Return on capital %36.319.6 185.2%  
Exports to sales %0.60-   
Imports to sales %12.60-   
Exports (fob) Rs m162NA-   
Imports (cif) Rs m3,322NA-   
Fx inflow Rs m26820,066 1.3%   
Fx outflow Rs m3,9275,304 74.0%   
Net fx Rs m-3,65914,762 -24.8%   
CASH FLOW
From Operations Rs m2,51410,127 24.8%  
From Investments Rs m-800-7,869 10.2%  
From Financial Activity Rs m-803-1,918 41.9%  
Net Cashflow Rs m912212 431.2%  

Share Holding

Indian Promoters % 0.0 71.5 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 7.0 112.5%  
FIIs % 0.1 12.6 0.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 8.8 194.3%  
Shareholders   18,270 26,511 68.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   ASTRAZENECA PHARMA  DR. DATSONS LABS  ELDER PHARMA  SANOFI INDIA  PANACEA BIOTECH  

Compare ABBOTT INDIA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Near Record High; Realty Stocks Bleed(Closing)

After opening the day on a strong note, share markets in India witnessed volatility during the last hour of trading session. However, they managed to end the day on a positive note.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

The ONLY Thing You Need to Know About Bitcoin(The 5 Minute Wrapup)

Jan 6, 2018

You either want it or you want to get as far away from it as possible - but Bitcoin is just the noise masking the REAL opportunity. Read about it here...

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Jan 18, 2018 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA - STERLING BIOTECH COMPARISON

COMPARE ABBOTT INDIA WITH

MARKET STATS